medical device investing AVITA Medical Announces Positive Interim Results from Cohealyx® Study Demonstrating Accelerated Time to Skin Grafting
medical device investing AVITA Medical Secures 10-Year BARDA Agreement Worth Up to $25.5M to Bolster U.S. Burn Emergency Preparedness
medical device investing AVITA Medical Secures 10-Year BARDA Agreement Worth Up to $25.5M to Bolster U.S. Burn Emergency Preparedness
medical device investing AVITA Medical Showcases Acute Burn and Wound Care Portfolio at ABA 2026, Featuring New Cohealyx Data
medical device investing AVITA Medical Showcases Acute Burn and Wound Care Portfolio at ABA 2026, Featuring New Cohealyx Data
medical device investing AVITA Medical to participate at the TD Cowen 46th Annual Health Care Conference
medical device investing Data at 2026 Boswick Burn & Wound Symposium highlight first integrated use of AVITA Medical technologies
medical device investing AVITA Medical: Pre-J.P. Morgan Update Highlights 2025 Revenue Growth, New Debt Facility, and 2026 Growth Outlook
medical device investing AVITA Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference
medical device investing AVITA Medical to Present at the Piper Sandler 37?? Annual Healthcare Conference
NevGold Announces Positive, Consistent Drill Results on Historic Gold Leach Pads Including 0.34% Antimony And 0.41 g/t Au Over 12.5 Meters; Path to Near-Term Antimony Production Continues
Domestic Metals Announces Closing of Final Tranche of Private Placement and Announces $7.0 million Financing
CHARBONE devoile son plan strategique 2026-2030 : une transformation vers un groupe integre de gaz industriels a haute valeur
CHARBONE Unveils its 2026-2030 Strategic Plan: A Transformation Towards an Integrated High-Value Industrial Gas Group
